FIBRINOGEN (HUMAN)

FIBRINOGEN (HUMAN) was reported 233 times

FIBRINOGEN (HUMAN) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL DYSFIBRINOGENAEMIA 2 0.1667
1 HAEMORRHAGE FOETAL 3 0.0566
2 HEPATITIS B E ANTIBODY POSITIVE 1 0.0455
3 FOETAL-MATERNAL HAEMORRHAGE 2 0.0417
4 PLEURAL INFECTION BACTERIAL 1 0.0256
5 PORTAL VEIN CAVERNOUS TRANSFORMATION 1 0.0244
6 FOETAL ANAEMIA 3 0.0229
7 INHIBITING ANTIBODIES POSITIVE 1 0.0175
8 VISCERAL VENOUS THROMBOSIS 1 0.0167
9 PORTOSPLENOMESENTERIC VENOUS THROMBOSIS 1 0.0164
10 VIRAL CARDIOMYOPATHY 1 0.0127
11 ANAEMIA FOLATE DEFICIENCY 2 0.0104
12 SHUNT THROMBOSIS 1 0.0101
13 ACINETOBACTER TEST POSITIVE 1 0.0052
14 RENAL GRAFT INFECTION 1 0.0043
15 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 1 0.0041
16 BUDD-CHIARI SYNDROME 1 0.0040
17 INFUSION SITE THROMBOSIS 1 0.0037
18 GASTROINTESTINAL ISCHAEMIA 1 0.0036
19 HEPATITIS B SURFACE ANTIBODY POSITIVE 1 0.0034
20 TRANSFUSION-RELATED ACUTE LUNG INJURY 1 0.0032
21 HEPATIC VEIN THROMBOSIS 1 0.0032
22 HEPATITIS B CORE ANTIBODY POSITIVE 1 0.0027
23 PRODUCT RECONSTITUTION QUALITY ISSUE 2 0.0022
24 HYPOPROTEINAEMIA 4 0.0021
25 IMMUNE-MEDIATED ENCEPHALITIS 1 0.0019
26 JUGULAR VEIN DISTENSION 1 0.0018
27 GRAFT COMPLICATION 1 0.0017
28 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
29 CAPILLARY LEAK SYNDROME 3 0.0014
30 HAEMORRHAGE IN PREGNANCY 2 0.0014
31 TONSIL CANCER 1 0.0012
32 POUCHITIS 1 0.0012
33 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
34 RED BLOOD CELLS URINE POSITIVE 1 0.0010
35 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
36 HYPOFIBRINOGENAEMIA 1 0.0010
37 BRAIN DEATH 3 0.0010
38 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
39 ACINETOBACTER INFECTION 1 0.0009
40 HYPOCHLORAEMIA 1 0.0009
41 CEREBRAL ARTERY EMBOLISM 1 0.0008
42 MONOCYTE COUNT DECREASED 1 0.0008
43 POSTPARTUM HAEMORRHAGE 1 0.0007
44 HYPERURICAEMIA 3 0.0007
45 HEPATITIS ACUTE 4 0.0006
46 ENTEROBACTER INFECTION 1 0.0006
47 TREATMENT DELAYED 1 0.0006
48 THROMBOPHLEBITIS 2 0.0006
49 AORTIC VALVE STENOSIS 1 0.0006
50 PNEUMOMEDIASTINUM 1 0.0006
51 SMALL INTESTINAL PERFORATION 1 0.0005
52 HYPOALBUMINAEMIA 4 0.0005
53 VENOUS THROMBOSIS 2 0.0005
54 FOETAL GROWTH RESTRICTION 3 0.0005
55 BLOOD LOSS ANAEMIA 1 0.0004
56 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
57 HYPERNATRAEMIA 2 0.0004
58 LYMPHOCYTE COUNT DECREASED 7 0.0004
59 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
60 COMPARTMENT SYNDROME 1 0.0004
61 PARTIAL SEIZURES 2 0.0004
62 SUBDURAL HAEMATOMA 5 0.0003
63 HAEMOTHORAX 1 0.0003
64 GASTROINTESTINAL NECROSIS 1 0.0003
65 STRIDOR 1 0.0003
66 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
67 PIGMENTATION DISORDER 2 0.0003
68 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
69 WOUND COMPLICATION 1 0.0003
70 POOR VENOUS ACCESS 3 0.0003
71 HAEMORRHAGIC DIATHESIS 1 0.0003
72 MYELODYSPLASTIC SYNDROME 4 0.0003
73 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
74 CYTOKINE RELEASE SYNDROME 5 0.0002
75 SHOCK HAEMORRHAGIC 2 0.0002
76 ESCHERICHIA INFECTION 2 0.0002
77 ANAPHYLACTOID REACTION 1 0.0002
78 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
79 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
80 EYE OPERATION 1 0.0002
81 HYPOCALCAEMIA 4 0.0002
82 BODY TEMPERATURE DECREASED 2 0.0002
83 PROTEIN URINE PRESENT 1 0.0002
84 NORMAL NEWBORN 1 0.0002
85 ACUTE PULMONARY OEDEMA 1 0.0002
86 PREMATURE LABOUR 1 0.0002
87 HEPATITIS B 1 0.0002
88 LARYNGEAL OEDEMA 1 0.0002
89 SWELLING OF EYELID 1 0.0002
90 ANAPHYLACTIC SHOCK 4 0.0002
91 HIATUS HERNIA 2 0.0002
92 ASPERGILLUS INFECTION 1 0.0002
93 DYSGRAPHIA 1 0.0002
94 APPETITE DISORDER 1 0.0002
95 CARDIAC FAILURE ACUTE 1 0.0001
96 DEFAECATION URGENCY 1 0.0001
97 HEPATOCELLULAR INJURY 2 0.0001
98 PRODUCT SUPPLY ISSUE 1 0.0001
99 ASCITES 4 0.0001
100 HYPOPHOSPHATAEMIA 1 0.0001
101 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
102 PULMONARY HAEMORRHAGE 1 0.0001
103 NEUTROPHIL COUNT DECREASED 5 0.0001
104 COAGULOPATHY 2 0.0001
105 LIVE BIRTH 1 0.0001
106 URINE OUTPUT DECREASED 1 0.0001
107 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
108 ANAL INCONTINENCE 1 0.0001
109 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
110 SINUS BRADYCARDIA 1 0.0001
111 INFLAMMATORY BOWEL DISEASE 1 0.0001
112 PREMATURE BABY 3 0.0001
113 MOTOR DYSFUNCTION 1 0.0001
114 MOUTH ULCERATION 2 0.0001
115 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
116 SKIN LACERATION 1 0.0001
117 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
118 BLOOD CALCIUM DECREASED 1 0.0001
119 PRODUCT AVAILABILITY ISSUE 2 0.0001
120 GASTRIC HAEMORRHAGE 1 0.0001
121 HYPOKALAEMIA 4 0.0001
122 EYELID OEDEMA 1 0.0001
123 DISEASE RECURRENCE 4 0.0001
124 C-REACTIVE PROTEIN INCREASED 3 0.0001
125 ADRENAL INSUFFICIENCY 1 0.0001
126 PLEURAL EFFUSION 5 0.0001
127 CEREBRAL INFARCTION 2 0.0001
128 PHARYNGITIS 1 0.0001
129 HEPATIC FUNCTION ABNORMAL 3 0.0001
130 LEUKOPENIA 4 0.0001
131 HAEMATOMA 2 0.0001
132 PLATELET COUNT INCREASED 1 0.0001
133 SARS-COV-2 TEST POSITIVE 1 0.0001
134 ABORTION SPONTANEOUS 3 0.0001
135 FREQUENT BOWEL MOVEMENTS 2 0.0001
136 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
137 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
138 TACHYPNOEA 1 0.0001
139 PROCEDURAL PAIN 2 0.0001
140 HYPOMAGNESAEMIA 1 0.0001
141 HYPOTENSION 14 0.0001
142 SEPTIC SHOCK 3 0.0001
143 LIVER FUNCTION TEST ABNORMAL 2 0.0001
144 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
145 HEPATIC FAILURE 2 0.0001
146 EPILEPSY 2 0.0001
147 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
148 ACUTE MYELOID LEUKAEMIA 1 0.0001
149 PNEUMOTHORAX 1 0.0001
150 PREMATURE DELIVERY 1 0.0001
151 DEEP VEIN THROMBOSIS 4 0.0001
152 STAPHYLOCOCCAL INFECTION 2 0.0001
153 BLOOD PRESSURE DECREASED 4 0.0001
154 FACE OEDEMA 1 0.0001
155 CIRCULATORY COLLAPSE 1 0.0001
156 HYPERKALAEMIA 2 0.0001
157 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
158 MYELOSUPPRESSION 2 0.0001
159 LEUKOCYTOSIS 1 0.0001
160 ANAPHYLACTIC REACTION 3 0.0001
161 BLOOD SODIUM DECREASED 1 0.0001
162 HAEMORRHOIDS 1 0.0001
163 ORAL HERPES 1 0.0001
164 BODY TEMPERATURE INCREASED 1 0.0000
165 CARDIO-RESPIRATORY ARREST 2 0.0000
166 ANAEMIA 9 0.0000
167 PLATELET COUNT DECREASED 5 0.0000
168 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
169 MELAENA 1 0.0000
170 SKIN DISCOLOURATION 2 0.0000
171 SHOCK 1 0.0000
172 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
173 MUSCULOSKELETAL PAIN 2 0.0000
174 BRADYCARDIA 2 0.0000
175 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
176 BLISTER 2 0.0000
177 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
178 INTENTIONAL PRODUCT MISUSE 3 0.0000
179 BLOOD POTASSIUM DECREASED 1 0.0000
180 HYPERTENSION 7 0.0000
181 DRUG-INDUCED LIVER INJURY 1 0.0000
182 PULMONARY EMBOLISM 3 0.0000
183 CYSTITIS 1 0.0000
184 LACTIC ACIDOSIS 1 0.0000
185 HEART RATE INCREASED 3 0.0000
186 HAEMATURIA 1 0.0000
187 RESPIRATORY FAILURE 2 0.0000
188 SEPSIS 3 0.0000
189 THROMBOCYTOPENIA 3 0.0000
190 INTESTINAL OBSTRUCTION 1 0.0000
191 BLOOD PRESSURE INCREASED 4 0.0000
192 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
193 THROMBOSIS 2 0.0000
194 PNEUMONIA 8 0.0000
195 RENAL IMPAIRMENT 2 0.0000
196 SKIN EXFOLIATION 2 0.0000
197 URINARY TRACT INFECTION 4 0.0000
198 ANGIOEDEMA 1 0.0000
199 TACHYCARDIA 2 0.0000
200 COLITIS ULCERATIVE 1 0.0000
201 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
202 SWELLING 2 0.0000
203 ARRHYTHMIA 1 0.0000
204 PRODUCTIVE COUGH 1 0.0000
205 BLOOD GLUCOSE DECREASED 1 0.0000
206 HYPOGLYCAEMIA 1 0.0000
207 HAEMATOCHEZIA 1 0.0000
208 OXYGEN SATURATION DECREASED 1 0.0000
209 COVID-19 3 0.0000
210 DYSPHONIA 1 0.0000
211 CHILLS 2 0.0000
212 DISEASE PROGRESSION 2 0.0000
213 CATARACT 1 0.0000
214 BLOOD CREATININE INCREASED 1 0.0000
215 FEBRILE NEUTROPENIA 1 0.0000
216 NEUTROPENIA 2 0.0000
217 PYREXIA 5 0.0000
218 INFECTION 2 0.0000
219 DIABETES MELLITUS 1 0.0000
220 OFF LABEL USE 11 0.0000
221 URTICARIA 2 0.0000
222 ANXIETY 3 0.0000
223 NEUROPATHY PERIPHERAL 1 0.0000
224 DYSPEPSIA 1 0.0000
225 SYNCOPE 1 0.0000
226 HAEMOGLOBIN DECREASED 1 0.0000
227 DRUG INEFFECTIVE 12 0.0000
228 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
229 ABDOMINAL PAIN 2 0.0000
230 OEDEMA PERIPHERAL 1 0.0000
231 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
232 RENAL FAILURE 1 0.0000
233 RASH 3 0.0000
234 PAIN IN EXTREMITY 2 0.0000
235 CONDITION AGGRAVATED 2 0.0000
236 DIZZINESS 3 0.0000
237 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
238 NO ADVERSE EVENT 1 0.0000
239 CHEST PAIN 1 0.0000
240 PRODUCT USE ISSUE 1 0.0000
241 ASTHENIA 2 0.0000
242 GAIT DISTURBANCE 1 0.0000
243 ERYTHEMA 1 0.0000
244 ABDOMINAL PAIN UPPER 1 0.0000
245 DIARRHOEA 3 0.0000
246 OVERDOSE 1 0.0000
247 VOMITING 2 0.0000
248 COUGH 1 0.0000
249 DYSPNOEA 2 0.0000
250 DEATH 3 0.0000
251 FALL 1 0.0000
252 PRURITUS 1 0.0000
253 FATIGUE 2 0.0000
254 MALAISE 1 0.0000
255 NAUSEA 1 0.0000